Yung-Jue Bang
New Generation University College
667 Papers
5.5K Citations
Yung-Jue Bang is an academic researcher from New Generation University College. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 94, co-authored 664 publications. Previous affiliations of Yung-Jue Bang include Seoul National University Hospital & Seoul National University.
Chat about Author
Papers
Involvement of NF-κB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein
Su Hyeong Kim,Jung Min Oh,Jae Hong No,Yung-Jue Bang,Yung-Jue Bang,Yong Sung Juhnn,Yong Sang Song +6 more
TL;DR: The findings collectively suggest that the HPV 16 E5 oncoprotein mediates cervical carcinogenesis at least in part via upregulation of COX-2 expression through NF-kappaB and AP-1, with NF- kappaB playing a larger role.
Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells.
Young-Kwang Yoon,Hwang-Phill Kim,Sae-Won Han,Hyung-Seok Hur,Do Youn Oh,Seock-Ah Im,Yung-Jue Bang,Tae-You Kim +7 more
TL;DR: The results provide the basis for a rational combination strategy against human EGFR WT gastric cancers, predicated on the understanding of cross-talk between the MEK and EGFR pathways.
The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines.
Jin Won Kim,Hwang-Phill Kim,Seock-Ah Im,Soyeong Kang,Hyung Seok Hur,Young-Kwang Yoon,Do-Youn Oh,Jee Hyun Kim,Jee Hyun Kim,Dong Soon Lee,Tae-You Kim,Yung-Jue Bang +11 more
TL;DR: The results provide a rationale for the future clinical trials of lapatinib combined with cytotoxic drugs in the treatment of HER2-positive gastric cancer.
Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial
Michael P. Chu,J. Randolph Hecht,Dennis J. Slamon,Zev A. Wainberg,Yung-Jue Bang,Paulo M. Hoff,Alberto Sobrero,Shukui Qin,Karen Afenjar,Vincent Houe,Karen King,Sheryl Koski,Karen E. Mulder,Julie A. Price Hiller,Andrew Scarfe,Jennifer L. Spratlin,Yingjie J. Huang,Saba Khan-Wasti,Neil Chua,Michael B. Sawyer +19 more
TL;DR: This secondary analysis of TRIO-013 compares capecitabine and oxaliplatin (CapeOx) with or without lapatinib in 545 patients with ERBB2/HER2-positive metastatic gastroesophageal cancer to determine if gastric acid suppressants such as proton pump inhibitors (PPIs) may impair cape citabine efficacy.
Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy.
Bhumsuk Keam,Seock-Ah Im,Youngil Koh,Sae-Won Han,Do-Youn Oh,Nariya Cho,Jee Hyun Kim,Wonshik Han,Keon Wook Kang,Woo Kyung Moon,Tae-You Kim,In Ae Park,Dong-Young Noh,June-Key Chung,Yung-Jue Bang +14 more
TL;DR: TheSerial FDG PET/CT after NAC could predict the pathologic status of ALN before surgery in stage II/III breast cancer and the combined use of serial FDGPET/CTs and chest CT might provide better information regarding ALn before surgery.